1
|
Surawicz TS, McCarthy BJ, Kupelian V, et
al: Descriptive epidemiology of primary brain and CNS tumors:
results from the Central Brain Tumor Registry of the United States,
1990–1994. Neuro Oncol. 1:14–25. 1999.PubMed/NCBI
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hadjipanayis CG and Van Meir EG: Tumor
initiating cells in malignant gliomas: biology and implications for
therapy. J Mol Med. 87:363–374. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Purow B and Schiff D: Advances in the
genetics of glioblastoma: are we reaching critical mass? Nat Rev
Neurol. 5:419–426. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Elmén J, Lindow M, Schütz S, et al:
LNA-mediated microRNA silencing in non-human primates. Nature.
452:896–899. 2008.PubMed/NCBI
|
6
|
Meister G and Tuschl T: Mechanisms of gene
silencing by double stranded RNA. Nature. 431:343–349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Tijsterman M and Plasterk RH: Dicers at
RISC; the mechanism of RNAi. Cell. 117:1–3. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
10
|
He H, Jazdzewski K, Li W, et al: The role
of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad
Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Metzler M, Wilda M, Busch K, et al: High
expression of precursor microRNA-155/BIC RNA in children with
Burkitt lymphoma. Genes Chromosomes Cancer. 39:167–169. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Murakami Y, Yasuda T, Saigo K, et al:
Comprehensive analysis of microRNA expression patterns in
hepatocellular carcinoma and non-tumorous tissues. Oncogene.
25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shigoka M, Tsuchida A, Matsudo T, et al:
Deregulation of miR-92a expression is implicated in hepatocellular
carcinoma development. Pathol Int. 60:351–357. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chen ZL, Zhao XH, Wang JW, et al:
microRNA-92a promotes lymph node metastasis of human esophageal
squamous cell carcinoma via E-cadherin. J Biol Chem.
286:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Haug BH, Henriksen JR, Buechner J, et al:
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor
DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis. 32:1005–1012.
2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Tsuchida A, Ohno S, Wu W, et al: miR-92 is
a key oncogenic component of the miR-17-92 cluster in colon cancer.
Cancer Sci. 102:2264–2271. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Spannuth WA, Sood AK and Coleman RL:
Angiogenesis as a strategic target for ovarian cancer therapy. Nat
Clin Pract Oncol. 5:194–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Arnoult D: Apoptosis-associated
mitochondrial outer membrane permeabilization assays. Methods.
44:229–234. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhou X, Ren Y, Moore L, et al:
Downregulation of miR-21 inhibits EGFR pathway and suppresses the
growth of human glioblastoma cells independent of PTEN status. Lab
Invest. 90:144–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Yamamichi N, Shimomura R, Inada K, et al:
Locked nucleic acid in situ hybridization analysis of miR-21
expression during colorectal cancer development. Clin Cancer Res.
15:4009–4016. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Yee KS, Wilkinson S, James J, et al: PUMA-
and Bax-induced autophagy contributes to apoptosis. Cell Death
Differ. 16:1135–1145. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Talotta F, Cimmino A, Matarazzo MR, et al:
An autoregulatory loop mediated by miR-21 and PDCD4 controls the
AP-1 activity in RAS transformation. Oncogene. 28:73–84. 2009.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Thaker NG and Pollack IF: Molecularly
targeted therapies for malignant glioma: rationale for
combinatorial strategies. Expert Rev Neurother. 9:1815–1836. 2009.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Nana-Sinkam SP and Croce CM: MicroRNAs as
therapeutic targets in cancer. Transl Res. 157:216–225. 2011.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Law PT and Wong N: Emerging roles of
microRNA in the intracellular signaling networks of hepatocellular
carcinoma. J Gastroenterol Hepatol. 26:437–449. 2011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Gandellini P, Profumo V, Folini M, et al:
MicroRNAs as new therapeutic targets and tools in cancer. Expert
Opin Ther Targets. 15:265–279. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Farazi TA, Spitzer JI, Morozov P, et al:
miRNAs in human cancer. J Pathol. 223:102–115. 2011. View Article : Google Scholar
|
29
|
Zhang CZ, Zhang JX, Zhang AL, et al:
MiR-221 and miR-222 target PUMA to induce cell survival in
glioblastoma. Mol Cancer. 9:2292010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Piñon JD, Labi V, Egle A, et al: Bim and
Bmf in tissue homeostasis and malignant disease. Oncogene.
27:S41–S52. 2008.PubMed/NCBI
|